MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Marker Therapeutics, Inc. Common Stock

MRKR

#3670
Marker Therapeutics, Inc. Common Stock
1.48
-5.13%
Sector:
Básica:
Profit Currency:
Rango diario
1.48
1.48
Rango anual
0.81
4.07
Cambio diario
-5.13%
Monthly Change
-19.57%
6 month change
+64.44%
Cambio anual
+1.37%
Cierres anteriores
1.56
Open
1.48
Bid
Ask
Low
1.48
High
1.48
Volumen
5
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. MRKR
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Investing Investing
MRKR
2026.02.09
Marker Therapeutics fija fecha para reunión anual de accionistas 2026
Investing Investing
MRKR
2026.02.09
Marker Therapeutics fija fecha para la junta anual de accionistas de 2026 y plazo de propuestas
Investing Investing
MRKR
2026.02.09
Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline
Zacks Zacks
MNKD FOLD MRKR KROS
2026.01.21
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
Zacks Zacks
IRWD RIGL SLNO MRKR
2026.01.08
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
Zacks Zacks
MRKR
2026.01.07
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
Zacks Zacks
SLNO IRWD RIGL MRKR
2026.01.07
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Investing Investing
MRKR
2026.01.06
Marker Therapeutics mantiene calificación de Compra en H.C. Wainwright
Investing Investing
MRKR
2026.01.06
Marker Therapeutics mantiene calificación de Compra en H.C. Wainwright
Investing Investing
MRKR
2026.01.06
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright
Investing Investing
MRKR
2026.01.05
Brookline Capital eleva el precio objetivo de las acciones de Marker Therapeutics a 5,60 dólares
Investing Investing
MRKR
2026.01.05
Brookline Capital eleva precio objetivo de Marker Therapeutics a $5.60

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd